Newsroom

News
How widespread are coronavirus antibodies in Osnabrück?
Mild or asymptomatic infections with the SARS coronavirus-2 are often not detected. Antibody studies can provide reliable information on what percentage of the population has already been infected with SARS-CoV-2. The Helmholtz Centre for Infection Research (HZI) in Braunschweig is coordinating a nationwide study to determine the spread of antibodies against SARS-CoV-2. Population samples will be examined in ten selected regions until summer 2021. From 14 October, around 3000 test persons from the city and district of Osnabrück will be invited to take part in the antibody test.
14.10.2020
HZI Campus
Fleisch
News
Investigation of a SARS-CoV-2 outbreak in German meat processing plant published in scientific journal
In a joint study of the Helmholtz Centre for Infection Research (HZI), the University Medical Center Hamburg-Eppendorf (UKE), and the Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology (HPI), the origins of the first SARS-CoV-2 outbreak in May 2020 at Tönnies in Rheda-Wiedenbrück, Germany's largest meat processing complex, were investigated. The study was published on the preprint platform SSRN in July 2020. The results have now been peer-reviewed and were published in the journal EMBO Molecular Medicine.
08.10.2020
HZI Campus
Portrait Emmanuelle Charpentier
News
Emmanuelle Charpentier Honored With the 2020 Nobel Prize in Chemistry
The Royal Swedish Academy of Sciences has awarded this year’s Nobel Prize in Chemistry to Emmanuelle Charpentier, former Head of the Department “Regulation in Infection Biology” at the Helmholtz Centre for Infection Research (HZI), Braunschweig, and Professor at the Hannover Medical School, Hannover, for her groundbreaking work on the CRISPR-Cas9 gene editing technology. She shares the prize with Jennifer A. Doudna.
07.10.2020
HZI Campus
Mann mit Maske
News
Together we can do it: Each individual contribution protects health, society, and the economy
Even though we have been living with the COVID- pandemic for more than half a year, there are still many unanswered questions and major uncertainties regarding further infection. How will the epidemic develop in Germany – especially during the upcoming flu season and the cold autumn and winter months? Which strategies are particularly effective in containing the rising number of infections in Germany and worldwide? What has proved successful in recent months? What properties of SARS-CoV- are now understood? And what measures can be imposed for the population and the economy without restricting social life too much?
24.09.2020
HZI Campus
Blutproben
News
HZI nationwide coronavirus antibody study comes to Aachen
Many SARS-coronavirus-2 infections are mild or completely asymptomatic and are therefore not detected. This makes it difficult to assess pandemic trends, prevention strategies and mortality rates. Antibody studies can provide reliable information on what percentage of the population has already been infected with SARS-CoV-2. In a nationwide study, the Helmholtz Centre for Infection Research (HZI) in Braunschweig is using regional samples to investigate the spread of antibodies against the novel coronavirus. The study examines about 3000 test persons in the urban region of Aachen from 9th September 2020.
09.09.2020
HZI Campus
Logo
News
Three ERC Starting Grants awarded to HZI
The European Research Council (ERC) awards three scientists from the Helmholtz Centre for Infection Research (HZI) with an ERC Starting Grant. The grants of up to 1.5 million Euros over a period of five years will be awarded to Jun Prof Neva Caliskan from the Helmholtz Institute for RNA-based Infection Research (HIRI), Jun Prof Gregor Fuhrmann from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Prof Yang Li from the Centre for Individualised Infection Medicine (CiiM).
03.09.2020
HZI Campus
CiiM
HIPS
HIRI

HZI in the media

Der Kot ist die Spur - Schüler forschen mit dem Helmholtz Institut

Die Schüler vom Greifswalder Alexander-von-Humboldt Gymnasium forschen in diesem Schuljahr zusammen mit Forschern ...

01.07.2024
|
Tagesschau
Schüler aus Greifswald forschen am Helmholtz-Zentrum

Sendung: NDR Info | 01.07.2024 | 14:00 Uhr

01.07.2024
|
NDR Norddeutscher Rundfunk
Wie schwere Ionen bei der Impfstoffentwicklung helfen können

Um Viren für Impfstoffe zu inaktivieren, werden oft Gammastrahlen verwendet. Forscher aus Darmstadt und Braunschweig ...

30.06.2024
|
FAZ.NET
RSV-Infektionen - Stiko empfiehlt Impfung – und eine neuartige Prophylaxe für Neugeborene

Für Neugeborene ist RSV lebensgefährlich, Winterkinder sollen auf der Entbindungsstation Antikörper bekommen © Getty Images Für ...

28.06.2024
|
MSN Deutschland
Welt der Bakterien entschlüsseln

Neuer Ansatz zur DNA-Transformation und Genmutation in Bakterien entwickelt: Grundlage für neue Antibiotika und ...

28.06.2024
|
Bionity.COM
Empfehlung der Ständigen Impfkommission zur RSV-Immunisierung

Respiratorische Synzytial-Viren (RSV) sind eine bedeutende Ursache für Atemwegsinfektionen, insbesondere bei Säuglingen und älteren ...

27.06.2024
|
ScienceMediaCenter